Substance / Medication

Saccharomyces boulardii

Overview

Active Ingredient
Saccharomyces boulardii
RxNorm CUI
236782

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy and Safety of <em>Saccharomyces Boulardii</em> with Standard Quadruple Therapy for Eradication of <em>Helicobacter Pylori </em>in Adults: Meta-Analysis.
Ma Fengzhen, Huang Heyin, Tian Kanglin et al. · J Coll Physicians Surg Pak · 2025
PMID: 41247686Meta-Analysis
Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication.
Jiang Yi-Zhou, Ma Kai, Cui Cheng et al. · BMC Gastroenterol · 2025
PMID: 40251486Meta-AnalysisFull text (PMC)
Systematic review with meta-analysis: Saccharomyces boulardii for treating acute gastroenteritis in children-a 2020 update.
Szajewska Hania, Kołodziej Maciej, Zalewski Bartłomiej M · Aliment Pharmacol Ther · 2020
PMID: 32056266Meta-Analysis
[Saccharomyces boulardii CNCM I-745 influences the gut-associated immune system].
Stier Heike, Bischoff Stephan C · MMW Fortschr Med · 2017
PMID: 28643294Meta-Analysis
Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection.
Szajewska H, Horvath A, Kołodziej M · Aliment Pharmacol Ther · 2015
PMID: 25898944Meta-Analysis
Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.
Szajewska H, Kołodziej M · Aliment Pharmacol Ther · 2015
PMID: 26216624Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Saccharomyces boulardii (substance)
SNOMED CT
700441006
UMLS CUI
C0772093
RxNorm CUI
236782

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.